Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Epstein-Barr Virus Infections × Matrix-M × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1 Epstein-Barr Virus Infections 1

Interventions

Cell Count 2 pomalidomide 1 Vincristine 1 Valproic Acid 1 Valganciclovir 1 Rituximab 1 Prednisone 1 Matrix-M 1 Gemcitabine 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04645147 2025-07-17

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡